ctrl K

Watchlist Price Alert

SAB Biotherapeutics Inc. (SABS)

NASDAQ: SABS · Real-Time Price · USD

1.77

-0.01 (-0.56%)

At close: Jun 27, 2025, 11:13 AM

SAB Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8.9M	56.57M	15.05M	33.21M	12.61M	6.35M
Short-Term Investments	11.86M	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	482.1K	350.23K	467.69K	n/a	n/a	n/a
Receivables	54.95K	n/a	5.56M	8.01M	20.57M	2.82M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.98M	2.34M	n/a	6.34M	n/a	n/a
Total Current Assets	23.79M	58.91M	22.1M	48.42M	34.46M	9.29M
Property-Plant & Equipment	19.92M	24.68M	28.34M	30.95M	22.08M	8.71M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	20.4M	25.03M	28.81M	30.95M	22.08M	8.71M
Total Assets	44.2M	83.94M	50.9M	79.37M	56.54M	18M
Account Payables	1.69M	945.93K	3.68M	4.46M	7.38M	2.17M
Deferred Revenue	n/a	1.32M	n/a	100K	100K	n/a
Short-Term Debt	811.84K	1.05M	1.4M	1.8M	538.73K	1.95M
Other Current Liabilities	5.47M	4.49M	7.47M	13.99M	1.17M	-4.12M
Total Current Liabilities	7.98M	10.81M	14.99M	24.68M	11.06M	4.62M
Long-Term Debt	n/a	n/a	541.64K	n/a	172.04K	53.45K
Other Long-Term Liabilities	6.39M	11.77M	320.93K	10.72M	n/a	15.64M
Total Long-Term Liabilities	10.25M	15.83M	4.85M	16.14M	6.47M	15.69M
Total Liabilities	18.23M	26.64M	19.85M	40.82M	17.53M	20.31M
Total Debt	4.67M	5.91M	5.93M	6.74M	8.13M	7.64M
Common Stock	935.00	929.00	5.09K	4.35K	3.52K	3.52K
Retained Earnings	-124.17M	-90.06M	-47.87M	-29.13M	-11.98M	-32.1M
Comprehensive Income	-135.41K	26.42K	n/a	n/a	n/a	n/a
Shareholders Equity	25.97M	57.3M	31.06M	38.55M	39.01M	-2.31M
Total Investments	11.86M	n/a	n/a	n/a	n/a	n/a